Monsanto is proposing to ban some chemical compounds that have been linked to autism and other neurological disorders, citing the risk of poisoning children.
The company is urging the Food and Drug Administration (FDA) to consider banning glyphosate and other glyphosate-based chemicals that have the potential to cause cancer, and to consider adding “other carcinogens” to its list of approved compounds.
Glyphosate is a major component of Monsanto’s Roundup weed-killer, which has been used to kill weeds for more than a decade.
The chemical is also used as an insecticide.
Monsanto’s plan to ban glyphosate comes as a new study has linked glyphosate exposure to a potentially deadly condition known as “mild cognitive impairment,” which can cause temporary cognitive impairment, a kind of memory loss.
The new study, published in the journal Neuropsychopharmacology, found that the chemical can cause mild cognitive impairment in people who have taken the chemical, which is classified as a “vitamin A precursor.”
It is unclear what the cause of mild cognitive impairments is, but studies have shown that exposure to glyphosate can lead to cognitive impairment.
A new study by researchers at University of Texas MD Anderson Cancer Center found that people who were exposed to glyphosate for a prolonged period had significantly higher rates of mild neurological symptoms, such as fatigue, confusion, memory loss, and anxiety.
According to a press release issued by Monsanto, the company is asking the FDA to consider limiting glyphosate exposure.
The FDA, however, has not yet made any recommendations regarding banning glyphosate.
“This is a decision that will be made based on our scientific assessment of the risk posed by the potential toxicity of these compounds to children and adults,” a Monsanto spokesperson told The Hill in a statement.
“We will continue to monitor this issue to ensure that we have the appropriate science to support this decision.
Glycine is a chemical found in Monsanto’s popular Roundup herbicide, which glyphosate is a part of.”
According to the release, the research study found that a “significant number of cases of mild impairment, including fatigue, decreased in the exposed individuals, which was significantly higher than in the unexposed.”
The company noted that “there are no reported adverse effects of the exposure, which are consistent with the use of glyphosate as a food preservative and pesticide.”
Monsatan has not responded to The Hill’s request for comment.
Montanto has also requested that the FDA review studies related to “carcinogenicity studies” to determine if the chemicals are safe.
The companies’ move to ban the chemical comes as the Food & Drug Administration has already begun to weigh in on the health impacts of glyphosate exposure in the United States.
The agency has proposed rules that would limit the use and sales of glyphosate, as well as the production of the chemical in the country.
The agency’s proposal, however will not be binding and will be reviewed by Congress.
Mondays Roundup Roundup Roundup is the first crop in the US to be sprayed with the herbicide in an attempt to combat weeds.
The Environmental Protection Agency (EPA) has also issued a preliminary draft of its proposed rules for glyphosate production and sale, which would require a more rigorous safety assessment before glyphosate can be sold.
Monsell, the chemical industry trade group, said in a press statement that the proposed rules would put Monsanto’s interests ahead of the health of consumers and farmers.
“The EPA’s draft rule has been crafted in a way that would protect the health and safety of farmers and consumers and would put the health interests of farmers ahead of those of Monsanto,” the statement said.
The statement continued: “We are concerned that the EPA has chosen to put Monsanto at a competitive disadvantage in this process by putting a strict regulatory burden on the company, while not providing any meaningful information about the risks associated with glyphosate. “
The proposed rule would also put Monsanto in a difficult position to defend itself against the EPA’s proposal to require that Monsanto test all glyphosate-containing products for carcinogenicity and for any other significant risks to the public.”
The statement continued: “We are concerned that the EPA has chosen to put Monsanto at a competitive disadvantage in this process by putting a strict regulatory burden on the company, while not providing any meaningful information about the risks associated with glyphosate.
A spokesperson for the American Chemistry Council (ACBC), a chemical industry lobbying group, told The Associated Press that the company was “looking forward to working with the EPA to craft meaningful rules to address glyphosate exposure.””
Monsantely is also actively pursuing a regulatory approach that would allow it to make changes to glyphosate to meet the needs of farmers who are suffering the most from the impacts of herbicides.”
A spokesperson for the American Chemistry Council (ACBC), a chemical industry lobbying group, told The Associated Press that the company was “looking forward to working with the EPA to craft meaningful rules to address glyphosate exposure.”
The ACBC also said that “any regulatory action by the EPA that restricts the use or sales of a pesticide would not be consistent with